|
OKYO OKYO Pharma Ltd 1849296 |
| Income Statement |
|
Net Income
|
2025-03-31
|
$-4,706,292.00 |
| Balance Sheet |
|
Current Assets
|
$3,675,301.00 |
|
Assets
|
$3,677,336.00 |
|
Current Liabilities
|
$9,226,891.00 |
|
Liabilities
|
$9,226,891.00 |
|
Equity
|
$-5,549,555.00 |
|
Shares Out
|
52479527.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-1,810,931.00 |
|
Investing Cash Flow
|
$-1,208.00 |
| Market Analysis |
Market Cap
|
$79,768,881.04 |
|
Price
|
$1.36 |
|
PB
|
38.71 |
|
EPS
|
-0.15 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:52 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:42 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view OKYO documents filed with the SEC.
OKYO Filings
Clear
